Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Lalwani Nikhil (CIK 1822629) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-16). Recent activity: Sell ANIP (5,400 shares), Sell ANIP (5,400 shares), Sell ANIP (55,000 shares), Sell ANIP (17,060 shares), Buy ANIP (75,592 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-16 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Sell | 5,400 | $383,400 |
| 2026-08-26 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Sell | 5,400 | $401,220 |
| 2026-05-13 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Sell | 55,000 | $4.3M |
| 2026-03-10 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Sell | 17,060 | $1.3M |
| 2026-03-02 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Buy | 75,592 | $5.8M |
| 2026-03-02 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Sell | 12,217 | $902,836 |
| 2026-02-17 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Sell | 11,688 | $896,470 |
| 2026-02-17 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Sell | 10,298 | $796,653 |
| 2026-02-13 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Sell | 30,659 | $2.3M |
| 2025-08-14 | ANI PHARMACEUTICALS INC (ANIP) | PRESIDENT & CEO | Sell | 56,960 | $4.9M |
Source: SEC Form 4 filings · as of 2026-09-16